 |
Uridine 5′-triphosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Primary ciliary dyskinesia |
| USA Market Approval | USA |
| USA Designation Date | 1996-06-26 00:00:00 |
| Sponsor | Inspire Pharmaceuticals, Inc.;4222 Emperor Boulevard, Suite 470;Durham, North Carolina, 27703 |
| |
Uridine 5′-triphosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Primary ciliary dyskinesia |
| USA Market Approval | USA |
| USA Designation Date | 1996-06-26 00:00:00 |
| Sponsor | Inspire Pharmaceuticals, Inc.;4222 Emperor Boulevard, Suite 470;Durham, North Carolina, 27703 |